Current options in the treatment of acute bronchospasm.
Asthma therapy has evolved significantly in the last 40 years from that used for primarily symptomatic relief to that which incorporates short-term relief agents, long-term preventive medications, and exacerbation relief products. Agents can now be prescribed for routine as well as emergency care. Continued development of medications are likely to offer patients better agents for control of their illness and mitigate occurrence of acute exacerbations. Better control allows for better patient health, reduced number of physician and emergency department visits, and reduced health care costs.
Berger
William E
WE
Department of pediatrics, division of allergy and immunology, College of Medicine, University of California, Irvine, USA. wberger@uci.edu
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy*; D001986:Bronchial Spasm / Q000175:diagnosis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D000420:Albuterol